Welcome to Drug Target Review. This site uses cookies. Read our policy.
Sponsored by Abzena2025-05-14T14:30:00
Watch our webinar with Abzena’s experts to explore practical solutions for overcoming chemistry, manufacturing and regulatory challenges in antibody-oligonucleotide conjugate (AOC) development, enabling progress for previously untreatable diseases.